about
Melanocyte stem cells as potential therapeutics in skin disordersPost-embryonic nerve-associated precursors to adult pigment cells: genetic requirements and dynamics of morphogenesis and differentiationCarvacrol derivatives as mushroom tyrosinase inhibitors; synthesis, kinetics mechanism and molecular docking studies.Cranial neural crest migration: new rules for an old road.From melanocyte to metastatic malignant melanomaSox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes.P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.Morphological and molecular characterization of dietary-induced pseudo-albinism during post-embryonic development of Solea senegalensis (Kaup, 1858)Melanoma characteristics in Brazil: demographics, treatment, and survival analysisThe evolving role of radiation therapy in the management of malignant melanomaFuture of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body.Semi-solid tumor model in Xenopus laevis/gilli cloned tadpoles for intravital study of neovascularization, immune cells and melanophore infiltration.The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanoma.Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.Comparison of cytotoxicity between extracts of Clinacanthus nutans (Burm. f.) Lindau leaves from different locations and the induction of apoptosis by the crude methanol leaf extract in D24 human melanoma cells.Constitutive gray hair in mice induced by melanocyte-specific deletion of c-Myc.Crystal structure of 2-(4-acetyl-anilino)-2-oxoethyl 3-(4-hy-droxy-phen-yl)propionate.RACK1 Function in Cell Motility and Protein Synthesis.Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma.In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer 68Ga-NODAGA-Procainamide (PCA).Protein and non-protein biomarkers in melanoma: a critical update.Molecular biology of normal melanocytes and melanoma cells.Molecular and cellular pathogenesis of melanoma initiation and progression.Therapeutic Implications of Newly Identified Stem Cell Populations From the Skin Dermis.The neural crest: a versatile organ system.Germline gene polymorphisms predisposing domestic mammals to carcinogenesis.Regulation of viability, differentiation and death of human melanoma cells carrying neural stem cell biomarkers: a possibility for neural trans-differentiation.Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic Readouts.Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.Quantitative comparison of the spreading and invasion of radial growth phase and metastatic melanoma cells in a three-dimensional human skin equivalent model.Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma.Dissecting the Mutational Landscape of Cutaneous Melanoma: An Omic Analysis Based on Patients from Greece.
P2860
Q27008330-E173976D-6D8B-4C66-B65E-360769E0CF02Q27341771-BB0C7BAD-0C9E-4CBA-9F03-11C344F62715Q33719531-C7AC895E-5654-4925-B6A5-E87DFDCD4E05Q34037222-7130B88A-C64F-4F51-9965-A9D2487E9A30Q34169935-E83DA83C-CEBD-45E7-8D45-0690E7477C55Q34170999-92D698AD-2469-44AA-91E4-E781BDBDB7EAQ34235334-F1E09405-9848-4B78-9468-8DAE3421BF5AQ34851389-EB5CA487-360B-40AA-A2E7-5F921CF0C5A2Q34998750-1F9E1395-B58A-45A5-A2CB-F16D3BC043D9Q35056773-6286C57F-8E87-47F9-A513-F88EFEEBE01FQ35221682-E64044E0-4AB6-4C27-BF35-9AA9F090BCBDQ35837191-50C0F38A-5262-406D-8F3D-DAC40283BE90Q35862805-0E1C30F2-734B-4E97-B9BA-E3B8670A41E6Q36097890-22C2512D-9705-43BE-A6CF-82DBCE09B174Q36109632-24238DE6-2896-4F96-959C-BE87E66C6AD5Q36137750-8841255E-2278-4654-A9ED-79EC062DC38BQ36521086-5DA14A53-581F-4432-809F-65F0F538AD24Q37193296-70CF8037-FFAD-4836-947C-C7EE4B870FDBQ37392549-0432F543-4241-4184-B7CA-F0FAF839C504Q37727531-31ABE900-D4F5-469D-A308-27769767648FQ37738077-DBA46B13-4D75-4F60-9457-F18364B9D75DQ38050990-F75FFB2B-D949-42A4-8819-9208FF705153Q38092784-371E9F6B-2D2D-46DC-8901-2F2619C0654DQ38093446-37118263-5A94-47FB-9173-A14A356BF726Q38223850-69CA18B9-CDE3-4D38-92A4-FC2A75006055Q38250192-FABF7E68-1454-4BF7-A538-83ADA024A5EBQ38635393-661DBA95-5BC4-4F65-AD18-5047A2013411Q38877894-93201772-823C-43BF-859E-F93021FFD6C6Q38915525-E8F3FAA4-C34C-47DA-9053-9C3952BEF80AQ40970657-10509DFD-4BD7-4840-8628-DE25CB31934FQ41508982-D0F4631A-6E9B-47A2-8479-2B08DC2326C1Q49689767-2864EB2C-2BBF-40B7-B7C5-F740F1ACA3FDQ51039567-D5E4ACD3-CDAD-4E1C-A53F-3BDA8435F594Q55397223-0EB525A2-6274-4FCA-BA0A-8A327932E69F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Melanocytes in development and cancer.
@en
Melanocytes in development and cancer.
@nl
type
label
Melanocytes in development and cancer.
@en
Melanocytes in development and cancer.
@nl
prefLabel
Melanocytes in development and cancer.
@en
Melanocytes in development and cancer.
@nl
P2860
P356
P1476
Melanocytes in development and cancer.
@en
P2093
Audrey Uong
Leonard I Zon
P2860
P356
10.1002/JCP.21935
P577
2010-01-01T00:00:00Z